Literature DB >> 7978397

Induction and recovery characteristics and hemodynamic responses to sevoflurane and halothane in children.

V Piat1, M C Dubois, S Johanet, I Murat.   

Abstract

The present study was designed to compare induction and recovery characteristics of sevoflurane and halothane anesthesia in children, and to assess the hemodynamic profile of both anesthetics during induction and maintenance of anesthesia. Thirty-four children (aged 9 mo-9 yr) scheduled for ambulatory surgery were allocated randomly to groups to receive either halothane (HALO, n = 17) or sevoflurane (SEVO, n = 17) in a mixture of O2 and N2O (40:60) for mask induction and maintenance of anesthesia. The inspired concentrations used for inhalation via a mask were increased every five breaths and were successively 1%, 2%, 3%, and 3.5% for HALO and 2%, 4%, 6%, and 7% for SEVO. After tracheal intubation, expired concentration was maintained at 1 minimum alveolar anesthetic concentration (MAC) corrected for age until skin closure. Analgesia was provided by epidural anesthesia using a mixture of plain 1% lidocaine and 0.25% bupivacaine. Induction and recovery characteristics as well as hemodynamic data were recorded. The two groups were identical in age, weight, and duration of anesthesia and surgery. Time to intubation was the same between groups. In the SEVO group, five children exhibited mild excitement, while in the HALO group, one mild laryngospasm and one transient cardiovascular deterioration were observed. In the SEVO group, a significant increase in heart rate (HR) was observed before tracheal intubation, but during maintenance of anesthesia HR and systolic arterial pressure (SAP) did not change compared to control values. In the HALO group, HR did not change throughout the study, whereas SAP remained significantly below control values throughout both induction and maintenance of anesthesia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7978397     DOI: 10.1213/00000539-199411000-00004

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

Review 1.  Sevoflurane in paediatric anaesthesia: a review.

Authors:  K L Goa; S Noble; C M Spencer
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

2.  Inhalational anaesthesia in emergency medicine using a new volatile--sevoflurane.

Authors:  R G Mitchell; N Nichol; A S Goldie; D J Steedman
Journal:  J Accid Emerg Med       Date:  1997-09

3.  Recent advances in pediatric anesthesia.

Authors:  Josef Holzki
Journal:  Korean J Anesthesiol       Date:  2011-05-31

Review 4.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

Review 5.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 6.  Clinical and economic factors important to anaesthetic choice for day-case surgery.

Authors:  E I Eger; P F White; M S Bogetz
Journal:  Pharmacoeconomics       Date:  2000-03       Impact factor: 4.981

7.  Comparison of speed of inhalational induction in children with and without congenital heart disease.

Authors:  Suruchi Hasija; Sandeep Chauhan; Pawan Jain; Arin Choudhury; Neelam Aggarwal; Ravinder Kumar Pandey
Journal:  Ann Card Anaesth       Date:  2016 Jul-Sep

8.  The relationship between expired concentration of sevoflurane and sympathovagal tone in children.

Authors:  Eric Wodey; Lotfi Senhadji; Patrick Pladys; François Carre; Claude Ecoffey
Journal:  Anesth Analg       Date:  2003-08       Impact factor: 6.627

9.  Comparison of TIVA and Desflurane Added to a Subanaesthetic Dose of Propofol in Patients Undergoing Coronary Artery Bypass Surgery: Evaluation of Haemodynamic and Stress Hormone Changes.

Authors:  Didem Onk; Tülin Akarsu Ayazoğlu; Oruç Alper Onk; Mehmet Aksüt; Murat Günay; Kultigin Turkmen; Aynur Özensoy; Çiğdem Yazıcı Ersoy; Abdulkadir Çoban
Journal:  Biomed Res Int       Date:  2016-07-27       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.